US Broker Ratings

Alkermes plc (ALKS) Stock Analysis: Exploring a Promising 29.98% Potential Upside

Alkermes plc (NASDAQ: ALKS), a biopharmaceutical company headquartered in Dublin, Ireland, is garnering attention from investors due to its robust product pipeline and impressive potential upside of nearly 30%. Operating..

Option Care Health, Inc. (OPCH) Stock Analysis: Promising Potential with a 6.02% Upside

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, stands out as a significant provider of home and alternate site infusion services across the United States...

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth with a 4.35% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector focusing on animal health, has captured investor attention with its impressive market cap of $12.12 billion and..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Exploring a 15% Potential Upside with Robust Revenue Growth

BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands out in the healthcare sector as a promising player in the biotechnology industry. With its innovative approach to developing transformative medicines for genetic diseases..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 14.34% Upside in the Global Eye Care Market

Alcon Inc. (NYSE: ALC), a leading player in the healthcare sector, focuses on pioneering eye care solutions that span the globe. As a key entity in the Medical Instruments &..

Tempus AI, Inc. (TEM) Stock Analysis: A Healthcare Tech Powerhouse with 34.59% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM) stands at the forefront of innovation in the healthcare sector, leveraging cutting-edge technology to deliver advanced diagnostic and analytical solutions. With a market capitalization of..

GSK plc (GSK) Investor Outlook: Evaluating a 5.75% Upside Potential in the Healthcare Giant

GSK plc (GSK), a venerable name in the healthcare sector, stands as a formidable player within the global drug manufacturing industry. With a market capitalization of $99.33 billion, this United..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Marvel with 16% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND) stands out in the biotechnology sector with its innovative approach to addressing unmet medical needs through TransCon-based therapies. As the healthcare industry continues to evolve,..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating Growth in the Diagnostics Sector with a 4.25% Upside

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a formidable entity in the healthcare sector, particularly within the Diagnostics & Research industry. With a market capitalization of $235.19 billion, this..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a 4.66% Potential Upside Amidst Industry Challenges

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a significant player in the global pharmaceutical industry, offering a diverse portfolio that spans across generic medications, active pharmaceutical ingredients, and innovative..

DaVita Inc. (DVA) Investor Outlook: Unpacking a 32% Potential Upside Amidst Healthcare Challenges

DaVita Inc. (NYSE: DVA), a leading player in the healthcare sector, specifically within the medical care facilities industry, presents a mixed yet intriguing opportunity for investors. With a market capitalization..

Cooper Companies, Inc. (COO) Investor Outlook: Navigating a 12% Upside Potential in Healthcare

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, has garnered significant attention from investors seeking opportunities in the medical instruments and supplies industry. Headquartered in..

Revvity, Inc. (RVTY) Stock Analysis: Navigating the Healthcare Diagnostics Landscape with a $13.55 Billion Market Cap

Revvity, Inc. (RVTY), a stalwart in the healthcare diagnostics and research industry, offers a diverse range of health sciences solutions, technologies, and services. With a market capitalization of $13.55 billion,..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 26.3% Potential Upside Amidst Strong Growth Metrics

AptarGroup, Inc. (NYSE: ATR) is capturing investor attention with its robust market position in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of..

Royalty Pharma plc (RPRX) Stock Analysis: Unveiling a Promising 15.47% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector as a unique player with a business model focused on acquiring biopharmaceutical royalties and funding innovation. Founded in 1996..

Veeva Systems Inc. (VEEV) Stock Analysis: Unpacking a Potential 39% Upside for Investors

Veeva Systems Inc. (NYSE: VEEV), a stalwart in the healthcare technology sector, is capturing investor attention with its robust market presence and promising growth metrics. With a current market cap..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring a 35.69% Potential Upside in the Biotech Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnological space, has garnered significant attention due to its promising pipeline of therapeutics based on ribonucleic acid interference (RNAi). As a..

Moderna, Inc. (MRNA) Stock Analysis: Navigating the Challenges Amidst a -45% Revenue Decline

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has captured the attention of investors worldwide with its innovative mRNA technology. However, recent financial metrics highlight significant challenges..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Unveiling a 10.98% Upside Potential in Healthcare

IQVIA Holdings, Inc. (NYSE: IQV), a titan in the healthcare sector, particularly in diagnostics and research, is making waves with its robust market presence and promising investor outlook. With a..

Masimo Corporation (MASI)

⚠️ No article content returned.

..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds